Infusion seems the popular consensus, but I'm not sure how much profit it actually turns. That's the real question.
If it were highly profitable you would have thought it would have been sold off a while ago, to avoid the first CR they promised would no longer be needed. For senior management they must have known this cash problem was coming for quite some time, which begs the question how did we come to this point.
- Forums
- ASX - By Stock
- CR and asset sale
Infusion seems the popular consensus, but I'm not sure how much...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.70 |
Change
-1.350(7.92%) |
Mkt cap ! $301.7M |
Open | High | Low | Value | Volume |
$16.50 | $16.50 | $15.52 | $571.1K | 35.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13 | $15.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.00 | 775 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13 | 15.580 |
2 | 320 | 15.560 |
1 | 2496 | 15.550 |
2 | 558 | 15.530 |
3 | 765 | 15.520 |
Price($) | Vol. | No. |
---|---|---|
16.000 | 775 | 2 |
16.200 | 500 | 1 |
16.500 | 63 | 1 |
17.100 | 900 | 1 |
17.500 | 511 | 2 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online